Products

BoneMetrics (US)
Gleamer
Clinical Decision Support & Reference
BoneMetrics automates orthopedic measurements from trauma X-rays, reducing variability and saving time with AI-calculated angles and distances for spinal deformities like scoliosis.
ChestView US
Gleamer
Radiology & Imaging AI
ChestView US by Gleamer SAS is an FDA-cleared AI-powered Computer-Assisted Detection (CADe) software for chest X-rays, assisting radiologists and emergency medicine physicians in detecting multiple pathologies and reducing reading times.

See all 2 products →

About Gleamer SAS

Gleamer SAS is a French medtech company that specializes in developing AI-powered solutions for medical imaging. Their mission is to enhance diagnostic accuracy, improve workflow efficiency, and reduce the workload for radiologists. Gleamer’s AI solutions are designed to integrate seamlessly into existing radiology workflows, providing automated measurements, worklist prioritization, and reporting assistance across various modalities, including X-ray, computed tomography (CT), and magnetic resonance imaging (MRI).

The company’s comprehensive AI copilot, Gleamer Copilot, offers clinically validated applications that analyze millions of patient exams annually. These tools function as a gateway for deploying diagnostic algorithms that process medical data to identify abnormalities in bone, chest, breast, and neurological scans. Gleamer’s product portfolio includes BoneView for bone trauma detection, ChestView for thoracic pathology detection, BoneAge for pediatric bone age assessment, BoneMetrics for musculoskeletal measurements, and BreastView for lesion detection and triage in mammography. They have also expanded into neurological and musculoskeletal MRI capabilities through acquisitions. Gleamer’s solutions are FDA-cleared and CE-marked, demonstrating their adherence to international standards for medical devices.

Focus Areas

AI-powered medical imaging radiology bone trauma detection pulmonary pathology detection breast cancer detection neurological MRI musculoskeletal MRI oncology imaging automated measurements worklist prioritization structured reporting

Business Intelligence

TechnologyCloud-native architecture, Gleamer Copilot®

What Physicians Need to Know

AI-Powered Medical Imaging Analysis
Gleamer specializes in AI solutions for analyzing medical images across various modalities, including X-ray, CT scans, and MRI. Their AI assists in the detection and interpretation of findings, aiming to improve diagnostic accuracy and efficiency for radiologists.
Bone Trauma Detection (BoneView)
BoneView is Gleamer's AI tool specifically designed for interpreting bone trauma on X-rays, helping to improve fracture detection.
Pulmonary Pathology Detection (ChestView)
ChestView is an AI solution for chest X-ray analysis, capable of detecting critical findings such as pneumothorax and early signs of cancer.
Musculoskeletal Measurements (BoneMetrics)
BoneMetrics automates musculoskeletal measurements on X-rays, streamlining workflows and supporting orthopedic decision-making by automating key angles and lengths.
Bone Age Estimation (BoneAge)
Gleamer offers BoneAge, an automated bone age assessment tool based on the Greulich & Pyle atlas, designed to save time and improve consistency in pediatric bone age assessment from hand radiographs.
Oncology Imaging & Breast Cancer Detection (BreastView)
Gleamer's portfolio includes solutions for breast lesion detection on mammography (BreastView 2D and 3D).
Neurodegenerative Conditions (Pixyl.Neuro.MS, Pixyl.Neuro.BV)
Through the acquisition of Pixyl, Gleamer now offers AI solutions for MRI analysis related to neurodegenerative conditions, such as Pixyl.Neuro.MS for Multiple Sclerosis and Pixyl.Neuro.BV for Brain Volumetry.
Workflow Optimization & Reporting Automation
Gleamer's solutions are designed to optimize radiology workflows by providing instant results, highlighting findings on worklists, and generating automated reports (AutoReport). This helps reduce repetitive tasks and accelerate turnaround times.
Diagnostic Accuracy & Safety Net
Gleamer's AI acts as a 'safety net' for radiologists, designed to catch subtle findings or rare pathologies that the human eye might miss, thereby improving detection sensitivity and accuracy.
Physician Tip

For physicians, Gleamer's AI solutions, integrated into their 'Copilot' platform, offer several advantages. They can expect improved diagnostic accuracy and productivity, with AI assisting in the detection and interpretation of X-rays, CTs, and MRIs. The tools are designed to save valuable time by automating tasks like musculoskeletal measurements and bone age assessment, and by generating automated reports. This allows radiologists to focus on higher-value clinical decisions. The AI acts as a safety net, helping to reduce missed anomalies and minimize errors, ultimately leading to enhanced patient care and reduced medico-legal risks. Gleamer's solutions are clinically proven, FDA-cleared, and CE-certified, ensuring reliability and compliance.

Gleamer's AI solutions are built for seamless integration into existing radiology workflows. Their 'GleamerOS' infrastructure unifies orchestration and product deployment with deep integrations into radiologists' RIS (Radiology Information System) and PACS (Picture Archiving and Communication System) and workstations. They offer flexible deployment options, including on-premise or cloud-based solutions, and are designed to connect effortlessly with PACS/RIS. The AutoReport feature is compatible with HL7/FHIR/DICOM SR standards, ensuring smooth and reliable integration with various healthcare data systems. Gleamer prioritizes security and compliance, with certifications like HIPAA and GDPR, and patient data pseudonymization.

Products by Gleamer SAS

2 products in the directory

BoneMetrics (US)
Gleamer
Clinical Decision Support & Reference
BoneMetrics automates orthopedic measurements from trauma X-rays, reducing variability and saving time with AI-calculated angles and distances for spinal deformities like scoliosis.
ChestView US
Gleamer
Radiology & Imaging AI
ChestView US by Gleamer SAS is an FDA-cleared AI-powered Computer-Assisted Detection (CADe) software for chest X-rays, assisting radiologists and emergency medicine physicians in detecting multiple pathologies and reducing reading times.

What the Web Says

Gleamer SAS is a French company specializing in AI-powered medical imaging software, particularly known for its BoneView product which detects fractures on X-rays. The company was acquired by RadNet, Inc. in March 2026 and operates under RadNet's DeepHealth subsidiary. Gleamer's software aims to improve diagnostic accuracy, enhance workflow efficiency, and reduce human error in medical image analysis. While product reviews highlight its effectiveness in fracture detection, especially in emergency settings, some discussions on Reddit indicate concerns about false positives in pediatric X-rays.

Overall: Positive

Strengths

  • Advanced AI algorithms enhance image quality and provide accurate interpretations.
  • BoneView effectively detects fractures on radiographs, reducing undetected fracture rates.
  • Improves diagnostic accuracy and workflow efficiency for healthcare professionals.
  • Intuitive interface allows for effortless navigation, annotation, and secure sharing of images.
  • Can prioritize reports and assist during nighttime care when radiologists' review might be delayed.
  • Integrates seamlessly with existing medical imaging systems.

Limitations

  • Some users on Reddit report concerns about false positives, particularly with BoneView in pediatric X-rays.
  • AI can sometimes miss things and overcall others.
  • Limited information available on employer reviews on major platforms like Glassdoor and Capterra.
  • Details on newer reporting products like Voice and AutoReport, and their error reporting and review steps, are not clearly described.
  • Training datasets for AI can be small, leading to potential data bias and privacy issues.

Based on reviews from: SoftwareWorld, AI Health Index, Gleamer Website, ITQlick, RadNet Press Release, PMC (PubMed Central), Gleamer Software Reviews (SoftwareWorld), Reddit, Fierce Biotech

Last updated: 2026-10-21

Videos

News, demos, and interviews about Gleamer SAS.

Loading videos...

Videos load interactively. If none appear, search YouTube for Gleamer SAS →

View all on YouTube

Press & Coverage

Business Wire
RadNet Acquires Gleamer, Making RadNet's DeepHealth the Largest Provider of Radiology Clinical AI Solutions Worldwide
RadNet acquired Gleamer SAS, integrating it into DeepHealth to become the largest provider of radiology clinical AI solutions worldwide, expanding DeepHealth's AI-powered health informatics solutions and services.
2026-03
European Biotechnology Magazine
Gleamer raises €27m in Series B funding round - European Biotechnology Magazine
Gleamer SAS raised €27 million in Series B funding to expand its AI solutions portfolio and accelerate international expansion, particularly in Europe and the United States.
2023-06
Radiology Business
X-ray-focused AI firm Gleamer raises $29.5M from venture capital firms, radiologists
Gleamer secured nearly $29.5 million in Series B financing from venture capital firms and radiologists, with plans to expand its product portfolio and headcount.
2023-06
Business Wire
Gleamer Joins Prestigious French Tech Next 120 Program and Internal Funding to Accelerate Global AI Radiology Vision
Gleamer was selected for the French Tech Next 120 program, recognizing its position as a leading tech champion and reinforcing its mission to redefine radiology through AI globally.
2025-06
Vestbee
Paris-based medtech startup Gleamer secures €4.5M for its OncoView product | Vestbee
Gleamer secured €4.5 million in co-funding from the French government for its OncoView project, an AI solution designed to assist radiologists in interpreting oncology CT scans.
2024-12
Imaging Technology News
RadNet Acquires Gleamer for $269M to Dominate Radiology AI Market
RadNet acquired Gleamer SAS for $269.3 million in an all-cash transaction, integrating it into DeepHealth to create the world's largest provider of radiology clinical AI solutions.
2026-03
The SaaS News
Gleamer Raises $27 Million in Series B - The SaaS News
Gleamer, a Paris-based manufacturer of AI-powered solutions for medical imaging, raised $27 million in Series B financing, bringing its total funds raised to €36 million.
2023-06
Imaging Technology News
RadNet Acquires Gleamer to Expand DeepHealth's Global Reach
RadNet's acquisition of Gleamer will augment DeepHealth's global commercial sales force and add a strong research and development team, expanding its AI-powered health informatics solutions and services.
2026-03

Frequently Asked Questions

Gleamer SAS specializes in AI-powered solutions for medical imaging, primarily focusing on X-ray analysis. Their current product line includes BoneView for bone trauma detection and ChestView for detecting pulmonary pathologies. While their core expertise is in X-ray, they are actively expanding their capabilities and exploring applications in other modalities like CT and MRI for future development.
Gleamer's AI solutions enhance diagnostic accuracy by providing a 'second eye' to detect subtle pathologies, reducing missed findings and improving confidence in diagnoses. For workflow efficiency, their tools automate repetitive tasks like lesion detection and measurement, streamline reporting through automated pre-analysis, and prioritize urgent cases, ultimately saving time for radiologists and optimizing overall departmental operations.
Gleamer's AI solutions, including BoneView and ChestView, have received CE Mark certification in Europe, signifying their compliance with European health, safety, and environmental protection standards. They are also actively pursuing FDA clearance in the United States to make their products available to a broader market, demonstrating their commitment to rigorous regulatory standards.
Gleamer typically offers flexible pricing models for its AI solutions, which can include per-study fees, subscription-based licenses, or enterprise-wide agreements, tailored to the specific needs and volume of each healthcare facility. The return on investment often comes from improved diagnostic accuracy leading to better patient outcomes, increased radiologist efficiency, reduced turnaround times, and potential for higher throughput, though specific ROI figures would depend on individual facility metrics.
Gleamer SAS provides comprehensive technical support and training to ensure seamless integration and effective use of their AI platforms. This includes initial onboarding and installation support, hands-on training for radiologists and technical staff, and ongoing customer support for any operational or technical queries. They also offer regular software updates and educational resources to help users maximize the benefits of their AI solutions.
Gleamer SAS has established strategic partnerships with various healthcare technology companies and research institutions to enhance its offerings and expand its reach. These collaborations often involve integrating Gleamer's AI into existing PACS or RIS systems, co-developing new AI applications, or participating in clinical research to validate and improve their algorithms. These partnerships help Gleamer to broaden its product ecosystem, accelerate innovation, and ensure compatibility with diverse healthcare IT infrastructures.
Gleamer SAS has demonstrated strong financial stability, backed by successful funding rounds and strategic investments, which supports their long-term vision for advancing AI in medical imaging. Their commitment to continuous research and development, coupled with a growing customer base and strategic partnerships, indicates a reliable and sustainable future. This stability ensures ongoing support, regular updates, and continued innovation for their AI solutions, providing healthcare facilities with a dependable partner for the long term.

Related Companies

Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]

Veeva Systems is a global leader in cloud-based software solutions specifically designed for the life sciences industry, including pharmaceutical and biotech companies. The company’s offerings are crucial for managing various aspects of drug development, pharmaceutical manufacturing, and commercial operations. Their platforms help clients navigate complex regulatory requirements, improve operational efficiency, and accelerate the delivery of […]

The University at Buffalo (UB) is a prominent public research university and a flagship institution of the State University of New York (SUNY) system. While UB itself is a broad academic institution, the provided URL (halsted.compbio.buffalo.edu) points to a specific area within UB focused on computational biology. This division is actively engaged in healthcare AI […]

SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]

Prenaital is an AI-driven healthcare company focused on revolutionizing maternal care by improving the early detection and management of high-risk pregnancies. Their AI models analyze ultrasound images to identify at-risk pregnancies, including those with abnormal fetal growth and a risk of preterm birth, with significantly higher accuracy than current clinical practices—detecting 25-50% more high-risk cases. […]

PHQ Screeners is a free, open-access resource maintained by Pfizer, providing a comprehensive suite of Patient Health Questionnaire (PHQ) and Generalized Anxiety Disorder (GAD-7) screening instruments. These tools were developed by Drs. Robert L. Spitzer, Janet B.W. Williams, and Kurt Kroenke with an educational grant from Pfizer, and are widely utilized in primary care and […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.